For research use only. Not for therapeutic Use.
Halobetasol (Ulobetasol) is a corticosteroid. Halobetasol can be used for research of severe localized psoriasis[1].
Cell Viability Assay[2]
| Catalog Number | R042086 |
| CAS Number | 98651-66-2 |
| Synonyms | (6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one |
| Molecular Formula | C22H27ClF2O4 |
| Purity | ≥95% |
| InChI | InChI=1S/C22H27ClF2O4/c1-11-6-13-14-8-16(24)15-7-12(26)4-5-19(15,2)21(14,25)17(27)9-20(13,3)22(11,29)18(28)10-23/h4-5,7,11,13-14,16-17,27,29H,6,8-10H2,1-3H3/t11-,13-,14-,16-,17-,19-,20-,21-,22-/m0/s1 |
| InChIKey | LEHFPXVYPMWYQD-XHIJKXOTSA-N |
| SMILES | CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C)F |
| Reference | [1]. Schwicker D, et al. A cost-comparison study: Ulobetasol versus clobetasol in severe localized psoriasis. J Dermatolog Treat. 1992;2(4):127-131. |
